Velpatasvir | Market Exclusivity | US | Dates | PharmaCompass.com

Please Wait

Applying Filters...

Grow Your Pharma Business Digitally

Find Suppliers : API/FDF
- Search Our Integrated Database
Services
Excipients
Drugs in Dev.
News
Blog
Market Place
Login

Velpatasvir
U.S. EXCLUSIVITIES

Mission CDMO team brings reliability, resourcefulness, & responsiveness in executing your development project.

Contact Supplier

Bora Pharmaceuticals- Making success more certain.

Contact Supplier

xyz-pharma-m-2024-10-07

Contact Supplier

Athena Pharmaceutiques is a Partner of Choice for Drug Delivery & Life Cycle Management.

Contact Supplier

Valsynthese, part of the SSE Group, is a CDMO focused on highly energetic and highly hazardous chemistry.

Contact Supplier

xyz-pharma-m-2024-10-07

Contact Supplier

Velpatasvir

ACCESS ALL DATA, CHEMISTRY

ACCESS ALL DATA
Browse all information
CHEMISTRY
Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

10 API Suppliers, 3 EU WC, 4 NDC API, 9 Listed Suppliers, $ API Reference Price

10 API Suppliers
3 EU WC
4 NDC API
9 Listed Suppliers
$ API Reference Price

DEVELOPMENTS

1 Drugs in Development

1 Drugs in Development

INTERMEDIATES

8 Intermediates Suppliers

8 Intermediates Suppliers

FINISHED DOSAGE FORMULATIONS

11 FDF Dossiers, 5 FDA Orange Book, 1 Europe, 2 Canada, 1 South Africa, 2 Listed Dossiers

11 FDF Dossiers
5 FDA Orange Book
1 Europe
2 Canada
1 South Africa
2 Listed Dossiers

RELATED EXCIPIENT COMPANIES

1 SPI Pharma, 3 DKSH, 1 Jai Radhe Sales, 3 Faran Shimi Pharmaceutical, 2 Boai NKY Pharmaceuticals Ltd, 9 Gangwal Healthcare, 2 Nanjing Well Pharmaceutical, 1 Actylis, 1 Aeon Procare, 1 Alcedo Pharmachem, 4 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 3 BASF, 5 Corel Pharma Chem, 5 DFE Pharma, 6 Gangwal Chemicals, 1 Huzhou Sunflower Pharmaceutical, 3 Ideal Cures Pvt Ltd, 1 Ingredion Pharma Solutions, 20 Kerry, 10 Microlex e.U, 2 Novo Excipients, 1 Pharmatrans-Sanaq, 3 Pluviaendo, 3 Prachin Chemical, 10 Roquette, 3 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 11 Sigachi Industries, 3 Vasa Pharmachem

1 SPI Pharma
3 DKSH
1 Jai Radhe Sales
3 Faran Shimi Pharmaceutical
2 Boai NKY Pharmaceuticals Ltd
9 Gangwal Healthcare
2 Nanjing Well Pharmaceutical
1 Actylis
1 Aeon Procare
1 Alcedo Pharmachem
4 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd
3 BASF
5 Corel Pharma Chem
5 DFE Pharma
6 Gangwal Chemicals
1 Huzhou Sunflower Pharmaceutical
3 Ideal Cures Pvt Ltd
1 Ingredion Pharma Solutions
20 Kerry
10 Microlex e.U
2 Novo Excipients
1 Pharmatrans-Sanaq
3 Pluviaendo
3 Prachin Chemical
10 Roquette
3 Shanghai Shenmei Pharmaceutical Technology Co., Ltd
11 Sigachi Industries
3 Vasa Pharmachem

EXCIPIENTS BY APPLICATIONS

49 Fillers, Diluents & Binders, 23 Direct Compression, 21 Coating Systems & Additives, 15 Disintegrants & Superdisintegrants, 13 Lubricants & Glidants, 12 Granulation, 11 Co-Processed Excipients, 11 Controlled & Modified Release, 10 Thickeners and Stabilizers, 9 Film Formers & Plasticizers, 4 Taste Masking, 3 Coloring Agents, 3 Parenteral, 2 Solubilizers, 2 Topical, 2 Rheology Modifiers, 2 Chewable & Orodispersible Aids, 1 API Stability Enhancers, 1 Emulsifying Agents

49 Fillers, Diluents & Binders
23 Direct Compression
21 Coating Systems & Additives
15 Disintegrants & Superdisintegrants
13 Lubricants & Glidants
12 Granulation
11 Co-Processed Excipients
11 Controlled & Modified Release
10 Thickeners and Stabilizers
9 Film Formers & Plasticizers
4 Taste Masking
3 Coloring Agents
3 Parenteral
2 Solubilizers
2 Topical
2 Rheology Modifiers
2 Chewable & Orodispersible Aids
1 API Stability Enhancers
1 Emulsifying Agents

DIGITAL CONTENT

7 NEWS #PharmaBuzz

7 NEWS #PharmaBuzz

GLOBAL SALES INFORMATION

1 Finished Drug Prices, 4 Annual Reports

1 Finished Drug Prices
4 Annual Reports

MARKET PLACE

9 APIs

9 APIs

PATENTS & EXCLUSIVITIES

163 US Patents, 20 US Exclusivities

163 US Patents
20 US Exclusivities

REF. STANDARDS & IMPURITIES

3 Others

3 Others

$ API Ref.Price (USD/KG) : 4,079 Xls

Filters

Reset all filters

Filters

FILTER :

filter Company Name Reset all filters

20 All

01 20GILEAD SCIENCES INC

filter Product Reset all filters

20 All

01 20SOFOSBUVIR; VELPATASVIR

filter Exclusivity Expiration Date Reset all filters

20 All

01 22023-07-14

02 22024-01-14

03 42025-04-27

04 22027-03-19

05 22027-09-19

06 42028-06-10

07 42028-12-10

filter Exclusivity Code Reset all filters

20 All

01 2M-264

02 4M-277

03 2ODE-293

04 4ODE-376

05 8PED

Product Main Page

GILEAD SCIENCES INC

Contact Supplier

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

SOFOSBUVIR; VELPATASVIR

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

Exclusivity Code

M-277

Exclusivity Expiration Date

2025-04-27

Application Number

208341

Product Number

2

Exclusivity Details

01

GILEAD SCIENCES INC

SOFOSBUVIR; VELPATASVIR

Medlab Asia & Asia Health

Not Confirmed

GILEAD SCIENCES INC

U.S.A

Medlab Asia & Asia Health

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

SOFOSBUVIR; VELPATASVIR

Exclusivity Code : M-277

Exclusivity Expiration Date : 2025-04-27

Application Number : 208341

Product Number : 2

Exclusivity Details :

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

GILEAD SCIENCES INC

Contact Supplier

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

SOFOSBUVIR; VELPATASVIR

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

Exclusivity Code

ODE-376

Exclusivity Expiration Date

2028-06-10

Application Number

208341

Product Number

2

Exclusivity Details

02

GILEAD SCIENCES INC

SOFOSBUVIR; VELPATASVIR

Medlab Asia & Asia Health

Not Confirmed

GILEAD SCIENCES INC

U.S.A

Medlab Asia & Asia Health

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

SOFOSBUVIR; VELPATASVIR

Exclusivity Code : ODE-376

Exclusivity Expiration Date : 2028-06-10

Application Number : 208341

Product Number : 2

Exclusivity Details :

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

GILEAD SCIENCES INC

Contact Supplier

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

SOFOSBUVIR; VELPATASVIR

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

Exclusivity Code

M-264

Exclusivity Expiration Date

2023-07-14

Application Number

208341

Product Number

2

Exclusivity Details

03

GILEAD SCIENCES INC

SOFOSBUVIR; VELPATASVIR

Medlab Asia & Asia Health

Not Confirmed

GILEAD SCIENCES INC

U.S.A

Medlab Asia & Asia Health

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

SOFOSBUVIR; VELPATASVIR

Exclusivity Code : M-264

Exclusivity Expiration Date : 2023-07-14

Application Number : 208341

Product Number : 2

Exclusivity Details :

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

GILEAD SCIENCES INC

Contact Supplier

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

SOFOSBUVIR; VELPATASVIR

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

Exclusivity Code

ODE-293

Exclusivity Expiration Date

2027-03-19

Application Number

208341

Product Number

2

Exclusivity Details

04

GILEAD SCIENCES INC

SOFOSBUVIR; VELPATASVIR

Medlab Asia & Asia Health

Not Confirmed

GILEAD SCIENCES INC

U.S.A

Medlab Asia & Asia Health

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

SOFOSBUVIR; VELPATASVIR

Exclusivity Code : ODE-293

Exclusivity Expiration Date : 2027-03-19

Application Number : 208341

Product Number : 2

Exclusivity Details :

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

GILEAD SCIENCES INC

Contact Supplier

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

SOFOSBUVIR; VELPATASVIR

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

Exclusivity Code

M-277

Exclusivity Expiration Date

2025-04-27

Application Number

208341

Product Number

1

Exclusivity Details

05

GILEAD SCIENCES INC

SOFOSBUVIR; VELPATASVIR

Medlab Asia & Asia Health

Not Confirmed

GILEAD SCIENCES INC

U.S.A

Medlab Asia & Asia Health

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

SOFOSBUVIR; VELPATASVIR

Exclusivity Code : M-277

Exclusivity Expiration Date : 2025-04-27

Application Number : 208341

Product Number : 1

Exclusivity Details :

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

GILEAD SCIENCES INC

Contact Supplier

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

SOFOSBUVIR; VELPATASVIR

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

Exclusivity Code

ODE-376

Exclusivity Expiration Date

2028-06-10

Application Number

208341

Product Number

1

Exclusivity Details

06

GILEAD SCIENCES INC

SOFOSBUVIR; VELPATASVIR

Medlab Asia & Asia Health

Not Confirmed

GILEAD SCIENCES INC

U.S.A

Medlab Asia & Asia Health

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

SOFOSBUVIR; VELPATASVIR

Exclusivity Code : ODE-376

Exclusivity Expiration Date : 2028-06-10

Application Number : 208341

Product Number : 1

Exclusivity Details :

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

GILEAD SCIENCES INC

Contact Supplier

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

SOFOSBUVIR; VELPATASVIR

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

Exclusivity Code

M-264

Exclusivity Expiration Date

2023-07-14

Application Number

208341

Product Number

1

Exclusivity Details

07

GILEAD SCIENCES INC

SOFOSBUVIR; VELPATASVIR

Medlab Asia & Asia Health

Not Confirmed

GILEAD SCIENCES INC

U.S.A

Medlab Asia & Asia Health

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

SOFOSBUVIR; VELPATASVIR

Exclusivity Code : M-264

Exclusivity Expiration Date : 2023-07-14

Application Number : 208341

Product Number : 1

Exclusivity Details :

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

GILEAD SCIENCES INC

Contact Supplier

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

SOFOSBUVIR; VELPATASVIR

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

Exclusivity Code

M-277

Exclusivity Expiration Date

2025-04-27

Application Number

214187

Product Number

2

Exclusivity Details

08

GILEAD SCIENCES INC

SOFOSBUVIR; VELPATASVIR

Medlab Asia & Asia Health

Not Confirmed

GILEAD SCIENCES INC

U.S.A

Medlab Asia & Asia Health

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

SOFOSBUVIR; VELPATASVIR

Exclusivity Code : M-277

Exclusivity Expiration Date : 2025-04-27

Application Number : 214187

Product Number : 2

Exclusivity Details :

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

GILEAD SCIENCES INC

Contact Supplier

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

SOFOSBUVIR; VELPATASVIR

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

Exclusivity Code

ODE-293

Exclusivity Expiration Date

2027-03-19

Application Number

208341

Product Number

1

Exclusivity Details

09

GILEAD SCIENCES INC

SOFOSBUVIR; VELPATASVIR

Medlab Asia & Asia Health

Not Confirmed

GILEAD SCIENCES INC

U.S.A

Medlab Asia & Asia Health

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

SOFOSBUVIR; VELPATASVIR

Exclusivity Code : ODE-293

Exclusivity Expiration Date : 2027-03-19

Application Number : 208341

Product Number : 1

Exclusivity Details :

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

GILEAD SCIENCES INC

Contact Supplier

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

SOFOSBUVIR; VELPATASVIR

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

Exclusivity Code

ODE-376

Exclusivity Expiration Date

2028-06-10

Application Number

214187

Product Number

2

Exclusivity Details

10

GILEAD SCIENCES INC

SOFOSBUVIR; VELPATASVIR

Medlab Asia & Asia Health

Not Confirmed

GILEAD SCIENCES INC

U.S.A

Medlab Asia & Asia Health

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

SOFOSBUVIR; VELPATASVIR

Exclusivity Code : ODE-376

Exclusivity Expiration Date : 2028-06-10

Application Number : 214187

Product Number : 2

Exclusivity Details :

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

1
2

Contact us
to update this info

Privacy policy
Terms and conditions
Disclaimers
LOOKING FOR A SUPPLIER?